Aion Therapeutic Stock Today
| ANTCF Stock | USD 0.01 0 84.21% |
Performance12 of 100
| Odds Of DistressOver 69
|
Aion Therapeutic is trading at 0.0105 as of the 29th of November 2024. This is a 84.21 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0105. Aion Therapeutic has more than 69 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Aion Therapeutic are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2023 and ending today, the 29th of November 2024. Click here to learn more.
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States. The company has 147.3 M outstanding shares. More on Aion Therapeutic
Moving against Aion Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aion Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Aion Therapeutic [ANTCF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aion Therapeutic's market, we take the total number of its shares issued and multiply it by Aion Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aion Therapeutic classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 147.3 M outstanding shares.
Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations.
Check Aion Therapeutic Probability Of Bankruptcy
Ownership AllocationAion Therapeutic holds a total of 147.3 Million outstanding shares. Aion Therapeutic shows 17.68 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aion Ownership Details
Aion Therapeutic Risk Profiles
| Mean Deviation | 24.33 | |||
| Standard Deviation | 58.1 | |||
| Variance | 3376.05 | |||
| Risk Adjusted Performance | 0.13 |
Aion Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aion Therapeutic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Aion Therapeutic Corporate Management
| Patricia Purdy | Co Sec | Profile | |
| Graham Simmonds | COO CEO | Profile | |
| FACS FAANS | Medical Director | Profile | |
| Paul Burke | Pres Pharmaceuticals | Profile |
Other Information on Investing in Aion Pink Sheet
Aion Therapeutic financial ratios help investors to determine whether Aion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aion with respect to the benefits of owning Aion Therapeutic security.